Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Geese WJ, Kopit J, Shaw JW, Gillison ML

Open source

DOI: 10.1056/nejmoa1602252
Published: 2016 Nov 10
Container: The New England journal of medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1602252,
  title = {Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.},
  author = {Ferris RL and Blumenschein G Jr and Fayette J and Guigay J and Colevas AD and Licitra L and Harrington K and Kasper S and Vokes EE and Even C and Worden F and Saba NF and Iglesias Docampo LC and Haddad R and Rordorf T and Kiyota N and Tahara M and Monga M and Lynch M and Geese WJ and Kopit J and Shaw JW and Gillison ML},
  year = {2016},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa1602252},
  url = {https://doi.org/10.1056/nejmoa1602252}
}

RIS

TY  - JOUR
TI  - Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
AU  - Ferris RL
AU  - Blumenschein G Jr
AU  - Fayette J
AU  - Guigay J
AU  - Colevas AD
AU  - Licitra L
AU  - Harrington K
AU  - Kasper S
AU  - Vokes EE
AU  - Even C
AU  - Worden F
AU  - Saba NF
AU  - Iglesias Docampo LC
AU  - Haddad R
AU  - Rordorf T
AU  - Kiyota N
AU  - Tahara M
AU  - Monga M
AU  - Lynch M
AU  - Geese WJ
AU  - Kopit J
AU  - Shaw JW
AU  - Gillison ML
PY  - 2016
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa1602252
UR  - https://doi.org/10.1056/nejmoa1602252
ER  -

APA

RL, F., Jr, B. G., J, F., J, G., AD, C., L, L., K, H., S, K., EE, V., C, E., F, W., NF, S., LC, I. D., R, H., T, R., N, K., M, T., M, M., M, L., WJ, G., J, K., JW, S., & ML, G. (2016). Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.. The New England journal of medicine. https://doi.org/10.1056/nejmoa1602252

Source records

pubmed · retrieved 2026-11-10T07:39:30.620Z